Consultant lobbyist
Danielle Flieler
Santis Health
- Meetings this Parliament
- 29
- Since Nov 2021
- 49
- Active registrations
- 12
Danielle Flieler's lobbying: the clients they represent and every meeting they've reported since November 2021.
← LobbyingReported meetings
-
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
ISED funding application
-
- Maggie Chi · Member of Parliament
- Helena Jaczek · Member of Parliament
- Raquel Dancho · Member of Parliament
- Lisa Hepfner · Member of Parliament
and 2 moreShow fewer
- Jibril Hussein · Intern, Health Canada (HC)
- Justine Frame · Policy Advisor, Health Canada (HC)
Communicating with government to increase investments in health research Read more
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
- Jibril Hussein · Intern, Health Canada (HC)
Supporting engagement on the value in curing type one diabetes across Canada by seeking funding for increased and innovative research.
-
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Supporting engagement on the value in curing type one diabetes across Canada by seeking funding for increased and innovative research.
-
- Michael Collins · VP of Health Promotion at PHAC, Health Canada (HC)
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
- Flordeliz Osler · Senator, Senate of Canada
- Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
- Michelle Owen · Director, Health Canada (HC)
Discussion on the use of AI/digital health and how that can help improve the profession and more efficient access to care for patients. Read more
Discussion on the health human resource issues facing dermatologists such as shortages, wait times and access to care for patients.
-
- Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
The impact of the health human resource crisis on the profession of dietitians including team based care programs and policy. Read more
The impact that food insecurity is having on the health of Canadians and what policies or programs the government should implement to help address this issue
-
- Alfred Aziz · Director, Health Canada (HC)
The impact that food insecurity is having on the health of Canadians and what policies or programs the government should implement to help address this issue Read more
The impact of the health human resource crisis on the profession of dietitians including team based care programs and policy.
-
- Justine Frame · Policy Advisor, Health Canada (HC)
Engage government officials regarding domestic manufacturing of seasonal and pandemic flu vaccine. Read more
Renewal of national vaccine strategy to close gaps in vaccination coverage for Canadians, especially among seniors.
-
- Jibril Hussein · Intern, Health Canada (HC)
Supporting engagement on the value in curing type one diabetes across Canada by seeking funding for increased and innovative research.
-
- Abir Chamoun · Office Manager, House of Commons
Our key priorities focus on addressing the chronic underfunding of community mental health organizations, advocating for long-term, sustainable funding models to ensure their full integration into the health care system, and increasing visibility and awareness of their critical role within government. Read more
-
- Jibril Hussein · Intern, Health Canada (HC)
Discussions on the restructuring of the Canadian Preventative Health Task Force
-
- Justine Frame · Policy Advisor, Health Canada (HC)
Supporting engagement on the value in curing type one diabetes across Canada by seeking funding for increased and innovative research.
-
- Justine Frame · Policy Advisor, Health Canada (HC)
Engage government officials regarding domestic manufacturing of seasonal and pandemic flu vaccine.
-
- Justine Frame · Policy Advisor, Health Canada (HC)
Continued support for life sciences funding and the emerging area of stem cell and regenerative medicine research. Lobbying is about building awareness about the field and the strength of talent that works within the field. Read more
-
- Jibril Hussein · Intern, Health Canada (HC)
Discussions on the restructuring of the Canadian Preventative Health Task Force Read more
Communicating with government to increase investments in health research
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
- Justine Frame · Policy Advisor, Health Canada (HC)
Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and device innovation and adoption, support and delivery new models of care, equitable healthcare access, and women’s health. Read more
Federal initiatives with respect to the Canadian Life Sciences strategy and intergovernmental policy, funding, legislative, and guideline changes.
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
-
- Danièle Henkel · Senator, Senate of Canada
Communicating with government to increase investments in health research Read more
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Engage government officials regarding domestic manufacturing of seasonal and pandemic flu vaccine. Read more
Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR.
Antimicrobial Resistance (AMR) - Identification of the need for a multi-sectoral stakeholder working group to pursue joint goals under a Pan-Canadian AMR strategy and to strengthen Canada's end-to-end research capacity in AMR.
-
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
Engage with government to strengthen the Priority Review of Drug Submissions process. Read more
Renewal of national vaccine strategy to close gaps in vaccination coverage for Canadians, especially among seniors.
Raise awareness regarding the potential risks to drug and vaccine supply for Canadian patients arising from new U.S. state-level reimportation legislation.
Engage government officials regarding domestic manufacturing of seasonal and pandemic flu vaccine.
-
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
- Jibril Hussein · Intern, Health Canada (HC)
Discussions on the restructuring of the Canadian Preventative Health Task Force Read more
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
-
- Maggie Chi · Parliamentary Secretary, Health Canada (HC)
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
- Bruce Randall · Director General of Medical Devices, Health Canada (HC)
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
and 1 moreShow fewer
- Jibril Hussein · Intern, Health Canada (HC)
Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and device innovation and adoption, support and delivery new models of care, equitable healthcare access, and women’s health. Read more
Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies
Federal science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry
Federal initiatives with respect to the Canadian Life Sciences strategy and intergovernmental policy, funding, legislative, and guideline changes.
Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
-
- Maggie Chi · Parliamentary Secretary, Health Canada (HC)
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
- Jibril Hussein · Intern, Innovation, Science and Economic Development Canada (ISED)
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
and 2 moreShow fewer
- Bruce Randall · Director General of Medial Devices, Health Canada (HC)
- Daniel MacDonald · Director General Office of Pharmaceutical Management, Health Canada (HC)
Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes. Read more
Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and device innovation and adoption, support and delivery new models of care, equitable healthcare access, and women’s health.
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
Federal initiatives with respect to the Canadian Life Sciences strategy and intergovernmental policy, funding, legislative, and guideline changes.
-
- Burton Bailey · Member of Parliament
- Matt Strauss · Member of Parliament
- Jibril Hussein · Intern, Health Canada (HC)
- Michael Davies · Director, Health Canada (HC)
and 1 moreShow fewer
- David Lee · Chief Regulatory Officer, Health Canada (HC)
Discussion on the health human resource issues facing dermatologists such as shortages, wait times and access to care for patients. Read more
Discussion on the use of AI/digital health and how that can help improve the profession and more efficient access to care for patients.
-
- Carina Gabriele · Director of Policy, Women and Gender Equality (WAGE)
Regulations and guidelines affecting women's health like breast cancer screening, access to innovative technology and precision medicine.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.